RTW Investments’s NeoGenomics NEO Stock Holding History

RTW Investments’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-311,111	Closed	-$10.6M	–	116
2021 Q4	$10.6M	Hold	311,111	–	–	0.16%	79
2021 Q3	$14.9M	Hold	311,111	–	–	0.22%	69
2021 Q2	$13.1M	Buy	+311,111	New	+$13.8M	0.2%	64
2020 Q3	–	Sell	-445,000	Closed	-$13.8M	–	93
2020 Q2	$13.8M	Buy	+445,000	New	+$12.3M	0.39%	48

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

RTW Investments's NEO Position: Q1 2022 in Review

RTW Investments sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 311,111 shares — an estimated $10.6M sold.

RTW Investments first reported a position in NEO in Q2 2020 and held it in 4 quarters. The position peaked at $14.9M in Q3 2021. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

RTW Investments reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
RTW Investments sold 311,111 NeoGenomics shares in Q1 2022, an estimated $10.6M.
RTW Investments first reported a position in NeoGenomics in Q2 2020 and held it in 4 quarters.
RTW Investments's NeoGenomics position peaked at $14.9M in Q3 2021.
280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on RTW Investments's 13F filing for Q1 2022, filed 16 May 2022.